+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Substance Abuse Treatment Market Research Report by Treatment, Product, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5460270
  • Report
  • April 2022
  • Region: Global
  • 214 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022
The Global Substance Abuse Treatment Market size was estimated at USD 5,089.69 million in 2021, USD 5,546.23 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.14% to reach USD 8,605.25 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Substance Abuse Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment, the market was studied across Alcohol Addiction Treatment and Nicotine Addiction Treatment.
  • Based on Product, the market was studied across Alcohol Dependence, Opioid Addiction, and Tobacco Addiction.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacies and Retail Pharmacies & Drug Stores.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Substance Abuse Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Substance Abuse Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Substance Abuse Treatment Market, including AbbVie Inc., Accord Healthcare Limited, Alkermes PLC, Amphastar Pharmaceuticals, Inc., BioCorRx, Inc., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Elite Pharmaceuticals, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Indivior, LFB Group, Mallinckrodt LLC, Novartis International AG, Pfizer Inc., Purdue Pharma L.P., Reckitt Benckiser Group PLC, Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Substance Abuse Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Substance Abuse Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Substance Abuse Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Substance Abuse Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Substance Abuse Treatment Market?
6. What is the market share of the leading vendors in the Global Substance Abuse Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Substance Abuse Treatment Market?
Frequently Asked Questions about the Global Substance Abuse Treatment Market

What is the estimated value of the Global Substance Abuse Treatment Market?

The Global Substance Abuse Treatment Market was estimated to be valued at $5089.7 Million in 2021.

What is the growth rate of the Global Substance Abuse Treatment Market?

The growth rate of the Global Substance Abuse Treatment Market is 9.1%, with an estimated value of $8605.3 Million by 2027.

What is the forecasted size of the Global Substance Abuse Treatment Market?

The Global Substance Abuse Treatment Market is estimated to be worth $8605.3 Million by 2027.

Who are the key companies in the Global Substance Abuse Treatment Market?

Key companies in the Global Substance Abuse Treatment Market include AbbVie Inc., Accord Healthcare Limited, Alkermes PLC, Amphastar Pharmaceuticals, Inc., BioCorRx, Inc., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Elite Pharmaceuticals, Inc. and Glenmark Pharmaceuticals Limited.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing cases of tobacco addiction across the globe
5.1.1.2. Increasing patient awareness and higher treatment seeking rate
5.1.1.3. Favorable efforts from the governments to curb the use of these substances
5.1.2. Restraints
5.1.2.1. Relatively high cost of the treatment and poor treatment compliance
5.1.3. Opportunities
5.1.3.1. Emerging number of treatment centers with partnerships with private recovery facilities
5.1.3.2. Growing introduction of new products and therapy coupled with better reimbursement options
5.1.4. Challenges
5.1.4.1. Increasing cases of discontinuation of behavioral therapies and patients opt for outpatient care
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Substance Abuse Treatment Market, by Treatment
6.1. Introduction
6.2. Alcohol Addiction Treatment
6.3. Nicotine Addiction Treatment
7. Substance Abuse Treatment Market, by Product
7.1. Introduction
7.2. Alcohol Dependence
7.3. Opioid Addiction
7.4. Tobacco Addiction
8. Substance Abuse Treatment Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Retail Pharmacies & Drug Stores
9. Americas Substance Abuse Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Substance Abuse Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Substance Abuse Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. AbbVie Inc.
13.2. Accord Healthcare Limited
13.3. Alkermes PLC
13.4. Amphastar Pharmaceuticals, Inc.
13.5. BioCorRx, Inc.
13.6. Cipla Limited
13.7. Dr. Reddy’s Laboratories Ltd.
13.8. Elite Pharmaceuticals, Inc.
13.9. GlaxoSmithKline PLC
13.10. Glenmark Pharmaceuticals Limited
13.11. Indivior
13.12. LFB Group
13.13. Mallinckrodt LLC
13.14. Novartis International AG
13.15. Pfizer Inc.
13.16. Purdue Pharma L.P.
13.17. Reckitt Benckiser Group PLC
13.18. Sanofi S.A.
13.19. Teva Pharmaceutical Industries Ltd.
13.20. Viatris Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: DYNAMICS
FIGURE 2. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT, 2021 VS 2027 (%)
FIGURE 3. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT, 2027
FIGURE 5. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION TREATMENT, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION TREATMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION TREATMENT, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION TREATMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 10. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2027
FIGURE 12. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL DEPENDENCE, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL DEPENDENCE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OPIOID ADDICTION, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OPIOID ADDICTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TOBACCO ADDICTION, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TOBACCO ADDICTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 19. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 21. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 26. ARGENTINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. INDONESIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. MALAYSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. PHILIPPINES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. SINGAPORE SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. SOUTH KOREA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. TAIWAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. THAILAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. NETHERLANDS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. QATAR SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. SAUDI ARABIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. SOUTH AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. UNITED ARAB EMIRATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 56. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SUBSTANCE ABUSE TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION TREATMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION TREATMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION TREATMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION TREATMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL ADDICTION TREATMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION TREATMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION TREATMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION TREATMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION TREATMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY NICOTINE ADDICTION TREATMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL DEPENDENCE, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL DEPENDENCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL DEPENDENCE, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL DEPENDENCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY ALCOHOL DEPENDENCE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OPIOID ADDICTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OPIOID ADDICTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OPIOID ADDICTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OPIOID ADDICTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY OPIOID ADDICTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TOBACCO ADDICTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TOBACCO ADDICTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TOBACCO ADDICTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TOBACCO ADDICTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TOBACCO ADDICTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. ARGENTINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. BRAZIL SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. CANADA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 45. MEXICO SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. AUSTRALIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. CHINA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. INDIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. INDONESIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. JAPAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. MALAYSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. PHILIPPINES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. SINGAPORE SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. SOUTH KOREA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. TAIWAN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. THAILAND SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. FRANCE SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. GERMANY SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. ITALY SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. NETHERLANDS SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. QATAR SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. RUSSIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. SAUDI ARABIA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. SOUTH AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. SPAIN SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. UNITED ARAB EMIRATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. UNITED KINGDOM SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: SCORES
TABLE 72. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: BUSINESS STRATEGY
TABLE 73. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 74. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: RANKING
TABLE 75. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 76. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: MERGER & ACQUISITION
TABLE 77. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 78. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 79. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 80. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 81. GLOBAL SUBSTANCE ABUSE TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Accord Healthcare Limited
  • Alkermes PLC
  • Amphastar Pharmaceuticals, Inc.
  • BioCorRx, Inc.
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Elite Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Indivior
  • LFB Group
  • Mallinckrodt LLC
  • Novartis International AG
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...